自然语言处理对心力衰竭的临床和研究应用
Michael P Girouard1, Alex J Chang2, Yilin Liang2
1Department of Cardiology, Kaiser Permanente San Francisco Medical Center, 2425 Geary Boulevard, San Francisco, CA, 94115, USA.
Heart failure reviews
|December 19, 2024
概括
自然语言处理 (NLP) 通过分析心力衰竭 (HF) 研究和患者护理的电子健康记录来推进医学. 这项技术改善了对HF的数据分析,诊断和治疗策略.
科学领域:
- 人工智能和机器学习
- 计算语言学计算语言学
- 医疗信息学医学信息学
背景情况:
- 自然语言处理 (NLP) 是人工智能的一个关键领域,专注于以计算方式理解人类语言.
- 在医学中,NLP方法越来越多地被应用,特别是在心力衰竭 (HF) 研究中,通过分析电子健康记录 (EHR) 数据.
- 电子健康记录中大量的非结构化和半结构化文本数据为医学进步带来了巨大的潜力.
研究的目的:
- 提供NLP方法论的全面概述.
- 审查NLP在心力衰竭领域的当前临床和研究应用.
- 探索NLP在医学研究和实践中的未来方向.
主要方法:
- 审查最先进的NLP技术.
- 对心力衰竭中NLP应用现有文献的分析.
- 识别新兴趋势和未来的研究途径.
主要成果:
- NLP显著增强了临床研究过程,包括队列组装,疾病表型和结果确定.
- NLP为HF的直接患者护理提供了潜在的改进,有助于早期检测,准确诊断和基于证据的管理.
- 该审查强调了NLP对在医疗保健中访问和使用文本数据的变革性影响.
结论:
- NLP是一种快速发展的技术,对心力衰竭的医学研究和临床实践都有深远的影响.
- 持续开发和应用NLP对于释放EHR数据的全部潜力至关重要.
- 未来的方向包括进一步整合NLP,以改善患者护理和医学发现.
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:22Heart Failure Drugs: β-Blockers
315
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
315
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
382
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
382
01:22Heart Failure Drugs: Diuretics
339
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
339
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
57
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
57
01:26Heart Failure Drugs: Inotropic Agents
516
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
516